For these analyses we selected subjects with dengue-resolved infections, no prior exposure to ZIKV and a detectable ex vivo IFN-γ T cell response to DENV NS3 and/or capsid proteins (indicated as “dengue-immune”). This evidence concerns the gene KRAS and dengue disease.